Precedex Logo
Precedex ®

US Intended for U.S. audiences

Indications and Safety Information

Precedex is indicated for sedation in nonintubated patients prior to and during surgical and other procedures and in intubated and mechanically ventilated patients during treatment in an intensive care setting.

Precedex should be administered by continuous infusion not to exceed 24 hours.

Caution should be exercised when administering Precedex to patients with advanced heart block and/or severe ventricular dysfunction.

Clinically significant episodes of bradycardia, sinus arrest and hypotension have been associated with Precedex infusion and may necessitate medical intervention.

Please see a more complete description of these and other Warnings and Precautions in the full prescribing information.

button

Preparation & Dilution

Ready-to-use Precedex is now available1

  • 4 mcg/mL concentration
  • Available in 50 mL and 100 mL sizes
  • Case sizes of 20 (50 mL) and 10 (100 mL)
  • No admixing required prior to use

For more information, download the Premix Brochure in the Resources & Tools section or visit www.hospira.com.

Dilution of Precedex concentrate (200 mcg/2 mL)1

Precedex 2 mL vial must be diluted in 0.9% sodium chloride solution prior to administration. Preparation of solutions is the same, whether for the loading dose or maintenance infusion.

To prepare the infusion:

  • Withdraw 2 mL of Precedex from the vial
  • Add to 48 mL of 0.9% sodium chloride injection for a total of 50 mL
  • Shake gently to mix well

Final concentration is 4 mcg/mL.

Compatibility1

Precedex has been shown to be COMPATIBLE when administered with the following intravenous fluids:

  • 5% dextrose in water
  • 0.9% sodium chloride in water
  • Lactated Ringer’s solution

Precedex is also compatible with a number of additional drugs. Please see full prescribing information for a complete list.1

Precedex has been shown to be INCOMPATIBLE when administered with the following drugs1:

  • Amphotericin B
  • Diazepam